UG Healthcare Corp. Ltd. (SG:8K7)
SGX:8K7
8K7 Stock Chart & Stats
S$0.10
>-S$0.01(-3.23%)
At close: 4:00 PM EST
S$0.10
>-S$0.01(-3.23%)
Day’s Range― - ―
52-Week RangeS$0.07 - S$0.12
Previous CloseN/A
Volume145.10K
Average Volume (3M)131.00K
Market Cap
S$49.28M
Enterprise ValueS$73.35M
Total Cash (Recent Filing)S$45.13M
Total Debt (Recent Filing)S$28.46M
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding623,825,800
10 Day Avg. Volume276,890
30 Day Avg. Volume131,003
Financial Highlights & Ratios
PEG Ratio0.48
Price to Book (P/B)0.43
Price to Sales (P/S)0.47
P/FCF Ratio-8.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained top-line expansion (51.8% year) provides a durable platform for scale economies, better utilization of manufacturing assets and stronger negotiating power with suppliers and customers. Over 2–6 months this supports margin recovery potential and reinvestment capacity if cost discipline improves.
Balance Sheet StrengthA strong equity base and modest leverage give the company financial flexibility to fund working capital, capex or absorb demand shocks without severe refinancing risk. This structural stability aids long-term operations and lowers default probability versus highly levered peers.
Integrated Manufacturing & DistributionOwning production while also distributing third-party products diversifies revenue sources and reduces dependence on single channels. Vertical integration supports margin capture on own brands, resiliency across demand cycles and strategic customer relationships that persist beyond short-term volatility.
Bears Say
Profitability PressureNegative operating and net margins indicate the business struggles to convert sales into sustainable profits. Structural cost pressures, pricing competition or input volatility could persist, limiting retained earnings and the ability to fund growth organically over the medium term.
Weak Cash GenerationA sharp decline in free cash flow and negative operating cash conversion constrain capital allocation, increase reliance on external funding, and limit capacity to service debt or invest in capacity. Persistent cash weakness undermines strategic flexibility and operational resilience.
Negative Returns & EarningsA negative return on equity and reported EPS deterioration signal the company is not delivering shareholder returns. Over months this limits retained capital for reinvestment, raises questions about operational efficiency, and may pressure strategic options if performance does not improve.
UG Healthcare Corp. Ltd. News
8K7 FAQ
What was UG Healthcare Corp. Ltd.’s price range in the past 12 months?
UG Healthcare Corp. Ltd. lowest share price was S$0.07 and its highest was S$0.12 in the past 12 months.
What is UG Healthcare Corp. Ltd.’s market cap?
UG Healthcare Corp. Ltd.’s market cap is S$49.28M.
When is UG Healthcare Corp. Ltd.’s upcoming earnings report date?
UG Healthcare Corp. Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 149 days.
How were UG Healthcare Corp. Ltd.’s earnings last quarter?
UG Healthcare Corp. Ltd. released its earnings results on Feb 11, 2026. The company reported -S$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.002.
Is UG Healthcare Corp. Ltd. overvalued?
According to Wall Street analysts UG Healthcare Corp. Ltd.’s price is currently Overvalued.
Does UG Healthcare Corp. Ltd. pay dividends?
UG Healthcare Corp. Ltd. pays a Notavailable dividend of S$0.003 which represents an annual dividend yield of N/A. See more information on UG Healthcare Corp. Ltd. dividends here
What is UG Healthcare Corp. Ltd.’s EPS estimate?
UG Healthcare Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does UG Healthcare Corp. Ltd. have?
UG Healthcare Corp. Ltd. has 623,825,800 shares outstanding.
What happened to UG Healthcare Corp. Ltd.’s price movement after its last earnings report?
UG Healthcare Corp. Ltd. reported an EPS of -S$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of UG Healthcare Corp. Ltd.?
Currently, no hedge funds are holding shares in SG:8K7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
UG Healthcare Corp. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.00%
12-Months-Change
Fundamentals
Return on Equity
-2.36%
Trailing 12-Months
Asset Growth
-1.01%
Trailing 12-Months
Company Description
UG Healthcare Corp. Ltd.
UG Healthcare Corp. Ltd. (8K7) is a prominent player in the healthcare sector, primarily focused on the manufacturing and distribution of medical gloves and other healthcare-related products. The company operates in various markets, providing essential products to hospitals, clinics, and healthcare providers worldwide. With a commitment to quality and innovation, UG Healthcare has established a strong reputation for its nitrile and latex gloves, catering to both the medical and industrial sectors.
Technical Analysis
Riverstone Holdings
―
Hyphens Pharma International Ltd.
―
Medtecs International Corporation Ltd.
―
Pharmesis International Ltd.
―
―